In pts w HF CKD established CVD or multiple RFs for CVD base decision to use a GLP 1 RA or SGLT2i independent of background use of metformin

By rray, 9 February, 2023
Detail (Long)
In pts w/ HF, CKD, established CVD, or multiple RFs for CVD, base decision to use a GLP-1 RA or SGLT2i independent of background use of metformin.